Cargando…
Loss of ZG16 is associated with molecular and clinicopathological phenotypes of colorectal cancer
BACKGROUND: Zymogen granule protein 16 (ZG16) is one of the most significantly down-regulated genes in colorectal cancer (CRC) tissues. This study aimed to further evaluate its expression changes and investigate its association with molecular and clinicopathological characteristics of CRC. METHODS:...
Autores principales: | Meng, Hui, Li, Wencai, Boardman, Lisa A., Wang, Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902988/ https://www.ncbi.nlm.nih.gov/pubmed/29661177 http://dx.doi.org/10.1186/s12885-018-4337-2 |
Ejemplares similares
-
ZG16 regulates PD-L1 expression and promotes local immunity in colon cancer
por: Meng, Hui, et al.
Publicado: (2020) -
Loss of ZG16 is regulated by miR-196a and contributes to stemness and progression of colorectal cancer
por: Chen, Xiaobing, et al.
Publicado: (2016) -
Identification of ZG16B as a prognostic biomarker in breast cancer
por: Lu, Haotian, et al.
Publicado: (2020) -
Conformational switches and redox properties of the colon cancer‐associated human lectin ZG16
por: Javitt, Gabriel, et al.
Publicado: (2021) -
ZG16 promotes T-cell mediated immunity through direct binding to PD-L1 in colon cancer
por: Meng, Hui, et al.
Publicado: (2022)